SeouLin Bioscience Co. Ltd. | Cash Flow
Fiscal year is January-December. All values KRW Millions.
2013
2014
2015
2016
2017
Net Income before Extraordinaries
4,160
2,682
1,761
4,158
2,268
Depreciation, Depletion & Amortization
646
808
824
779
1,074
Other Funds
-
19
1,582
-
-
Funds from Operations
2,352
4,187
3,636
4,166
3,185
Changes in Working Capital
2,587
1,447
480
1,411
1,884
Net Operating Cash Flow
4,939
2,739
4,117
2,755
1,301
Capital Expenditures
89
1,128
3,743
7,214
9,544
Sale of Fixed Assets & Businesses
-
3
-
3,231
734
Purchase/Sale of Investments
5,970
230
499
7,781
4,303
Net Investing Cash Flow
5,682
1,587
4,222
3,732
5,020
Cash Dividends Paid - Total
598
650
676
737
776
Issuance/Reduction of Debt, Net
3,249
1,800
316
4,589
1,577
Net Financing Cash Flow
2,651
2,438
1,207
5,372
2,372
Net Change in Cash
1,910
1,287
1,101
1,121
1,386
Free Cash Flow
4,883
1,978
497
2,868
7,425
Net Assets from Acquisitions
-
-
-
65
90
Other Sources
690
16
20
15
187
Change in Capital Stock
-
7
15
46
1,571
Exchange Rate Effect
2
2
1
6
40
Other Uses
316
705
-
16
610
About SeouLin Bioscience Co.
View Profile
